DE3751269D1 - Expression des biologisch aktiven Faktors XIII. - Google Patents

Expression des biologisch aktiven Faktors XIII.

Info

Publication number
DE3751269D1
DE3751269D1 DE3751269T DE3751269T DE3751269D1 DE 3751269 D1 DE3751269 D1 DE 3751269D1 DE 3751269 T DE3751269 T DE 3751269T DE 3751269 T DE3751269 T DE 3751269T DE 3751269 D1 DE3751269 D1 DE 3751269D1
Authority
DE
Germany
Prior art keywords
proteins
biological activity
same biological
factor xiii
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3751269T
Other languages
English (en)
Other versions
DE3751269T2 (de
Inventor
Earl W Davie
Ronald L Seale
Akitada Ichinose
Julie Ann Holly
Gary E Parker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Zymogenetics Inc
Original Assignee
University of Washington
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Zymogenetics Inc filed Critical University of Washington
Publication of DE3751269D1 publication Critical patent/DE3751269D1/de
Application granted granted Critical
Publication of DE3751269T2 publication Critical patent/DE3751269T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE3751269T 1986-09-19 1987-09-18 Expression des biologisch aktiven Faktors XIII. Expired - Lifetime DE3751269T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90951286A 1986-09-19 1986-09-19

Publications (2)

Publication Number Publication Date
DE3751269D1 true DE3751269D1 (de) 1995-06-01
DE3751269T2 DE3751269T2 (de) 1995-09-14

Family

ID=25427353

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3751269T Expired - Lifetime DE3751269T2 (de) 1986-09-19 1987-09-18 Expression des biologisch aktiven Faktors XIII.

Country Status (7)

Country Link
EP (1) EP0268772B1 (de)
JP (4) JP2667405B2 (de)
AT (1) ATE121776T1 (de)
AU (1) AU615634B2 (de)
CA (1) CA1341577C (de)
DE (1) DE3751269T2 (de)
DK (1) DK175919B1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3621371A1 (de) * 1986-03-12 1987-09-17 Behringwerke Ag Gentechnische herstellung von faktor xiiia
US6869790B1 (en) 1986-03-12 2005-03-22 Aventis Behring Gmbh Preparation of DNA encoding factor XIIIA
US7220556B1 (en) 1986-03-12 2007-05-22 Zlb Behring Gmbh Preparation of factor XIIIa by gene manipulation
JPH01216939A (ja) * 1988-02-24 1989-08-30 Hoechst Japan Kk 末熟児頭蓋内出血阻止剤
US5204447A (en) * 1988-11-14 1993-04-20 Zymogenetics, Inc. Purification of factor xiii
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
DE3906540A1 (de) * 1989-03-02 1990-09-13 Behringwerke Ag Expressionsvektoren zur synthese von proteinen in der spalthefe schizosaccharomyces pombe
DE3940651A1 (de) * 1989-12-08 1991-06-13 Behringwerke Ag Verfahren zur expression von fremdgenen in hefen
AU7586991A (en) * 1990-03-21 1991-10-21 Board Of Regents, The University Of Texas System Yeast expression vectors
JPH0478519U (de) * 1990-11-16 1992-07-08
AU1268192A (en) * 1991-01-04 1992-08-17 Board Of Regents, The University Of Texas System Cloning and expression of tissue transglutaminases
ATE171071T1 (de) * 1991-12-31 1998-10-15 Zymogenetics Inc Verfahren und zusammensetzungen zur verminderung von blutverlust
WO1994010296A1 (en) * 1992-11-03 1994-05-11 Oklahoma Medical Research Foundation Transglutaminase gene
AU674061B2 (en) * 1993-03-30 1996-12-05 Hoechst Japan Limited Factor XIII for treatment of skin wounds
WO1996021025A1 (en) * 1994-12-30 1996-07-11 Zymogenetics, Inc. Bovine factor xiii
WO1999058699A2 (en) * 1998-05-14 1999-11-18 Battelle Memorial Institute Transgenic plant-derived human blood coagulation factors
DE60128130T2 (de) * 2000-11-03 2007-12-27 Zymogenetics, Inc., Seattle Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a
DE10101962B4 (de) * 2001-01-17 2006-07-27 Tad Pharma Gmbh DNA-Sequenz mit regulatorischen Bereichen zur Expression von Proteinen
ES2303561T3 (es) 2001-10-09 2008-08-16 Zymogenetics, Inc. Metodo para inhibir la formacion de seromas utilizando el factor xiii.
JP2008510476A (ja) 2004-08-27 2008-04-10 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 生物学的材料からのｘｉｉｉ因子ポリペプチドの精製
WO2006056575A1 (en) 2004-11-23 2006-06-01 Zymogenetics, Inc. Purification of recombinant human factor xiii
WO2010131249A2 (en) 2009-05-12 2010-11-18 Hadasit Medical Research Services And Development Ltd. Prosthetic devices coated with heated cross-linked fibrin
KR101799151B1 (ko) * 2015-07-09 2017-11-17 정용식 비닐하우스의 고정 끈의 장력 조절 연결 구조체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6029687B2 (ja) * 1978-11-07 1985-07-12 株式会社ミドリ十字 ヒト胎盤由来血液凝固第１０３因子の濃縮液の製造方法
DE3587759T2 (de) * 1984-05-11 1994-07-07 Chiron Corp., Emeryville, Calif. Erhöhte Hefetranskription unter Verwendung einer Hybridkonstruktion der Promotorregion.
DK27885A (da) * 1985-01-22 1986-07-23 Novo Industri As Fremstilling af peptider
DE3621371A1 (de) * 1986-03-12 1987-09-17 Behringwerke Ag Gentechnische herstellung von faktor xiiia

Also Published As

Publication number Publication date
JP3450844B2 (ja) 2003-09-29
DK491487D0 (da) 1987-09-18
EP0268772A2 (de) 1988-06-01
EP0268772B1 (de) 1995-04-26
ATE121776T1 (de) 1995-05-15
JP3077121B2 (ja) 2000-08-14
JP2002223756A (ja) 2002-08-13
AU7869487A (en) 1988-03-31
DK175919B1 (da) 2005-06-27
DK491487A (da) 1988-03-20
JPH09327296A (ja) 1997-12-22
DE3751269T2 (de) 1995-09-14
JPH11127873A (ja) 1999-05-18
EP0268772A3 (en) 1988-10-26
AU615634B2 (en) 1991-10-10
CA1341577C (en) 2008-07-22
JPS63164890A (ja) 1988-07-08
JP2667405B2 (ja) 1997-10-27
JP3299192B2 (ja) 2002-07-08

Similar Documents

Publication Publication Date Title
DE3751269D1 (de) Expression des biologisch aktiven Faktors XIII.
NZ218332A (en) Il-4(interleukin-4), recombinant production, dna, vectors and pharmaceutical composition
FI19992064A (fi) Menetelmä erytropoietiinin valmistamiseksi
EP0293443A4 (de) Herstellung synthetischer dns und deren verwendung bei der synthese grosser polypeptide.
ATE91722T1 (de) Pferde-gamma-interferon.
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
IL88151A (en) Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it
DE68925869D1 (de) Modifizierte Proteine, modifizierte Interferone alpha- und beta-phosphorylierte Proteine, DNA-Sequenzen und Analoge und deren Verwendung
DK192189D0 (da) Polypeptid, fremgangsmaade til inhibering af fibrinogen, fremgangsmaade til rensning af et polypeptid, gen indeholdende rekombinante dna kodende for et polypeptid, vektor, cellekultur og fremgangsmaade til fremstilling af et cysteinrigt polypeptid
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
ATE346919T1 (de) Nebenhoden-spezifisches rezeptorprotein und dessen verwendung
ES2083352T3 (es) Produccion de proteinas activas que contienen residuos de cisteina.
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
ATE87977T1 (de) Herstellung menschlichen somatomedins c.
DK128687D0 (da) Proteiner samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition